Article
EU regulator recommends revoking authorisation for Novartis' sickle cell drug
Rating:
0.0
Views:
51
Likes:
1
Library:
1
The European Medicines Agency (EMA) said on Friday it had recommended revoking marketing authorisation for Novartis' sickle cell disease drug Adakveo.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value